Cervical Cancer Awareness Week: 21 – 27 January 2019

January 21-27 is Cervical Cancer Prevention Week, and to mark the event, the Informa Pharma Intelligence Report Store is offering 20% off of the following essential cervical cancer market reports. Just enter the following voucher code at checkout to receive 20% discount: cervical20

Related Reports

Cervical cancer is a major gynecological cancer which involves uncontrolled cell division and tissue invasiveness of the female uterine cervix. Incidence rates are highest in sub-Saharan Africa, Latin America and the Caribbean, and Oceania/Australasia, and lowest in Western Asia, Australia/New Zealand, and Northern America. Human papillomavirus (HPV) is a major cause of the main types of cervical cancer (the two main histological subtypes being squamous cell cancer and adenocarcinoma), and is believed to be responsible for around 95% of cervical cancers.

This Market Spotlight report covers the cervical cancer market, comprising key pipeline and marketed drugs, clinical trials, upcoming events, patent information, a 10-year disease prevalence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.